Published in Biochim Biophys Acta on February 21, 2005
Lipoprotein(a) metabolism: potential sites for therapeutic targets. Metabolism (2012) 1.08
The ancillary protein 1 of Streptococcus pyogenes FCT-1 pili mediates cell adhesion and biofilm formation through heterophilic as well as homophilic interactions. Mol Microbiol (2012) 0.85
Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects. Clin Res Cardiol Suppl (2015) 0.81
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab (2010) 3.29
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol (2005) 3.21
A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol (2007) 2.47
The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol Biol Cell (2007) 2.42
Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology (2003) 1.98
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation (2004) 1.92
Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials (2012) 1.79
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem (2003) 1.74
Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol (2011) 1.73
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J (2006) 1.64
Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study. Arch Med Res (2008) 1.59
Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction. J Am Coll Cardiol (2012) 1.55
Effect of long-term interactive music therapy on behavior profile and musical skills in young adults with severe autism. J Altern Complement Med (2007) 1.52
Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun (2006) 1.51
Raised plasma nerve growth factor levels associated with early-stage romantic love. Psychoneuroendocrinology (2005) 1.51
Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol (2006) 1.50
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem (2006) 1.44
The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. J Biol Chem (2004) 1.42
Statins and hepatitis C virus: friend or foe? Hepatology (2010) 1.42
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism. J Psychosom Res (2006) 1.42
Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J Bacteriol (2010) 1.40
Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology (2005) 1.37
Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials (2010) 1.35
The tandem beta-zipper model defines high affinity fibronectin-binding repeats within Staphylococcus aureus FnBPA. J Biol Chem (2007) 1.32
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol (2005) 1.30
Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Mol Microbiol (2007) 1.26
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens (2005) 1.26
The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun (2011) 1.25
Fibrinogen-binding proteins of Gram-positive bacteria. Thromb Haemost (2007) 1.23
Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis. Microbiology (2008) 1.22
Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin Biochem (2004) 1.21
MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection. Curr Opin Drug Discov Devel (2004) 1.21
Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett (2005) 1.19
Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis (2007) 1.18
The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun (2011) 1.16
The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect Immun (2004) 1.16
The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials (2009) 1.16
Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. Blood (2010) 1.15
From DNA repair to proteome protection: new molecular insights for preventing non-melanoma skin cancers and skin aging. J Drugs Dermatol (2014) 1.13
Is the GehD lipase from Staphylococcus epidermidis a collagen binding adhesin? J Biol Chem (2002) 1.12
Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J (2006) 1.12
A multiplex PCR method for the detection of all five individual genes of ica locus in Staphylococcus epidermidis. A survey on 400 clinical isolates from prosthesis-associated infections. J Biomed Mater Res A (2005) 1.12
Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin Lab Med (2006) 1.12
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica (2009) 1.10
Extracellular DNA in biofilms. Int J Artif Organs (2011) 1.10
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. Diabetes Care (2002) 1.08
Effect of electrospun fiber diameter and alignment on macrophage activation and secretion of proinflammatory cytokines and chemokines. Biomacromolecules (2011) 1.07
Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol (2012) 1.06
An experimental double-blind irradiation study of a novel topical product (TPF 50) compared to other topical products with DNA repair enzymes, antioxidants, and growth factors with sunscreens: implications for preventing skin aging and cancer. J Drugs Dermatol (2014) 1.05
Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother (2007) 1.05
Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP. FASEB J (2009) 1.04
Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J Lipid Res (2013) 1.04
Effects of electromagnetic stimulation on calcified matrix production by SAOS-2 cells over a polyurethane porous scaffold. Tissue Eng (2006) 1.02
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
Preliminary evidence of a genetic association between chromosome 9p21.3 and human longevity. Rejuvenation Res (2010) 1.01
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis (2005) 1.01
Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles. Clin Biochem (2006) 1.00
FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood (2004) 1.00
Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. J Biol Chem (2003) 0.99
Iron-regulated surface determinant (Isd) proteins of Staphylococcus lugdunensis. J Bacteriol (2012) 0.99
Staphylococcus lugdunensis, an aggressive coagulase-negative pathogen not to be underestimated. Int J Artif Organs (2012) 0.99
Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections. Biomaterials (2005) 0.98
Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs (2011) 0.97
Human adipose-derived stem cells (hASCs) proliferate and differentiate in osteoblast-like cells on trabecular titanium scaffolds. J Biomed Mater Res A (2010) 0.97
Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol (2003) 0.96
Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies. J Clin Microbiol (2005) 0.96
Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation. Curr Vasc Pharmacol (2010) 0.96
Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus. Int J Artif Organs (2011) 0.96
Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol (2009) 0.95
Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease. Neurosci Lett (2004) 0.95
Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets. Microbiology (2009) 0.94
Sequence diversity in the A domain of Staphylococcus aureus fibronectin-binding protein A. BMC Microbiol (2008) 0.94
Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis. Blood (2007) 0.94
Fibronectin-binding protein B variation in Staphylococcus aureus. BMC Microbiol (2010) 0.94
Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts. Hum Genet (2002) 0.93